Over the last six months, Teleflex’s shares have sunk to $113.26, producing a disappointing 13% loss - a stark contrast to ...

Teleflex (NYSE: TFX) reported its Q4 earnings results on Thursday, February 26, 2026 at 06:30 AM. Here's what investors need to know about the announcement. Teleflex missed estimated earnings by -48.4 ...

Medical technology company Teleflex (NYSE:TFX) will be reporting results tomorrow before market hours. Here’s what to expect.

What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected ...

Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular and peripheral vascular intervention devices WAYNE, Pa., Feb. 27, 2025 ...

As of Thursday, February 26, Teleflex Incorporated’s TFX share price has surged by 7.09%, which has investors questioning if this is right time to sell.

Teleflex TFX posted solid fourth-quarter performance, ending the year on a stable note. On one hand, currency was a major headwind across all segments this fiscal year, and supply chain and staffing ...

Ratings for Teleflex (NYSE:TFX) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below ...

As a reminder, the board made its decision to transition the Chief Executive Officer position following the announced sale of ...

Teleflex faces a complex transition after divesting major business units at low multiples, creating uncertainty around future ...

Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter 2025 financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, February 26, ...

Teleflex stock (NYSE: TFX), best known for its single-use medical devices for common diagnostic and therapeutic procedures, has seen a 31% fall this year, underperforming the broader S&P500 index, ...